Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of the axilla in postmenopausal patients with cN0 hormone receptor-positive/HER2-negative breast cancer treated with neoadjuvant endocrine therapy and its prognostic impact.
Garcia-Tejedor A, Falo C, Fernandez-Gonzalez S, Laplana M, Gil-Gil M, Soler-Monso T, Martinez-Perez E, Calvo I, Calpelo H, Bajen MT, Benitez A, Ortega R, Petit A, Guma A, Campos M, Stradella A, Lopez-Ojeda A, Ponce J, Pla MJ, Pernas S. Garcia-Tejedor A, et al. Breast Cancer Res Treat. 2023 Jun;199(3):445-456. doi: 10.1007/s10549-023-06926-y. Epub 2023 Apr 12. Breast Cancer Res Treat. 2023. PMID: 37043108
The Shift From Sentinel Lymph Node Biopsy Performed Either Before or After Neoadjuvant Systemic Therapy in the Clinical Negative Nodes of Breast Cancer Patients. Results, and the Advantages and Disadvantages of Both Procedures.
Fernandez-Gonzalez S, Falo C, Pla MJ, Pernas S, Bajen M, Soler T, Ortega R, Quetglas C, Perez-Martin X, Fernandez Montoli ME, Campos M, Varela-Rodriguez M, Ponce J, Garcia-Tejedor A. Fernandez-Gonzalez S, et al. Clin Breast Cancer. 2018 Feb;18(1):71-77. doi: 10.1016/j.clbc.2017.08.014. Epub 2017 Sep 4. Clin Breast Cancer. 2018. PMID: 29030106
Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?
Garcia-Tejedor A, Fernandez-Gonzalez S, Ortega R, Gil-Gil M, Perez-Montero H, Fernandez-Montolí E, Stradella A, Recalde S, Soler T, Petit A, Bajen MT, Benitez A, Guma A, Campos M, Pla MJ, Martinez E, Laplana M, Pernas S, Perez-Sildekova D, Catala I, Ponce J, Falo C. Garcia-Tejedor A, et al. Breast Cancer Res Treat. 2021 Feb;185(3):657-666. doi: 10.1007/s10549-020-05970-2. Epub 2020 Oct 17. Breast Cancer Res Treat. 2021. PMID: 33068198
Risk Factors for Recurrence after Robot-Assisted Radical Hysterectomy for Early-Stage Cervical Cancer: A Multicenter Retrospective Study.
Ponce J, Fernandez-Gonzalez S, Gil-Moreno A, Coronado PJ, De la Rosa J, Nabais H, Hernández G, Taltavull A, Gilabert-Estelles J, Martínez-Román S, Barahona M, Barahona M, Martínez-Maestre MÁ. Ponce J, et al. Cancers (Basel). 2020 Nov 16;12(11):3387. doi: 10.3390/cancers12113387. Cancers (Basel). 2020. PMID: 33207627 Free PMC article.
The Impact of Surgical Practice on Oncological Outcomes in Robot-Assisted Radical Hysterectomy for Early-Stage Cervical Cancer, Spanish National Registry.
Fernandez-Gonzalez S, Ponce J, Martínez-Maestre MÁ, Barahona M, Gómez-Hidalgo NR, Díaz-Feijoo B, Casajuana A, Gracia M, Frias-Gomez J, Benavente Y, Costas L, Martí L, Melero L, Silvan JM, Beiro E, Lobo I, De la Rosa J, Coronado PJ, Gil-Moreno A. Fernandez-Gonzalez S, et al. Cancers (Basel). 2022 Jan 29;14(3):698. doi: 10.3390/cancers14030698. Cancers (Basel). 2022. PMID: 35158966 Free PMC article.
Cost-effectiveness analysis of molecular testing in minimally invasive samples to detect endometrial cancer in women with postmenopausal bleeding.
Peremiquel-Trillas P, Gómez D, Martínez JM, Fernández-González S, Frias-Gomez J, Paytubi S, Pelegrina B, Pineda M, Brunet J, Ponce J, Matias-Guiu X, Bosch X, de Sanjosé S, Bruni L, Alemany L, Costas L, Díaz M. Peremiquel-Trillas P, et al. Br J Cancer. 2023 Aug;129(2):325-334. doi: 10.1038/s41416-023-02291-1. Epub 2023 May 10. Br J Cancer. 2023. PMID: 37165201 Free PMC article.
Ovarian cancer relies on the PDGFRβ-fibronectin axis for tumorsphere formation and metastatic spread.
Gendrau-Sanclemente N, Figueras A, Gracova K, Lahiguera Á, Alsina-Sanchís E, Marín-Jiménez JA, Vidal A, Matias-Guiu X, Fernandez-Gonzalez S, Barahona M, Martí L, Ponce J, Viñals F. Gendrau-Sanclemente N, et al. Among authors: fernandez gonzalez s. Mol Oncol. 2024 Jan;18(1):136-155. doi: 10.1002/1878-0261.13556. Epub 2023 Dec 1. Mol Oncol. 2024. PMID: 38010623 Free PMC article.
69 results